Physician profile
Liana G Apostolova
NPI 1770508699
$95,224.07
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $8,235 · 2021: $5,805 · 2022: $35K · 2023: $38K · 2024: $8,565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Travel and Lodging: $9,573 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,524 · Food and Beverage: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $34,075.00 |
| Travel and Lodging | $9,573.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,524.00 |
| Food and Beverage | $162.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $30,357.14 | 2021-2024 | |
| Eli Lilly and Company | $17,482.58 | 2021-2023 | |
| Biogen, INC. | $14,221.00 | 2020-2022 | |
| Roche Diagnostics Corporation | $5,424.00 | 2022-2023 | |
| Alnylam Pharmaceuticals INC. | $5,150.00 | 2023 | |
| Corium, LLC | $4,960.00 | 2022 | |
| Siemens Medical Solutions USA, INC. | $4,800.00 | 2023 | Advia Centaur Xp Analyzer |
| F. Hoffmann-La Roche Ag | $4,485.00 | 2024 | |
| Genentech, INC. | $2,920.95 | 2022 | |
| Roche Products Limited | $2,760.00 | 2022 | |
| Genentech USA, INC. | $2,070.00 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $593.40 | 2022-2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Liana Apostolova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.